Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Some common medications can harm male fertility, but many effects can be reversed.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Long-term finasteride use doesn't change bone density or metabolism.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Minoxidil effectively treats female pattern hair loss.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Finasteride doesn't affect bone density in male rats.